Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Radiotherapy With Dose Escalated Concomitant Boost for Breast Cancer: a Phase 2 Trial

NCT07021846 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Campus Bio-Medico as lead sponsor.

NCT NCT07021846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07021846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Radiotherapy With Dose Escalated Concomitant Boost for Breast Cancer: a Phase 2 Trial
Lead sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Phase
Not applicable
Overall status
Recruiting
Start date
March 12, 2020
Completion date
March 31, 2030
Enrollment
132 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer